Accuracy of pathologic examination in detection of complete response after chemoradiation for esophageal cancer.

[1]  M. Mooney,et al.  Neoadjuvant and adjuvant chemotherapy for esophageal adenocarcinoma , 2005, Journal of Surgical Oncology.

[2]  Hao Wang,et al.  Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  K. Hunt,et al.  Proposed Revision of the Esophageal Cancer Staging System to Accommodate Pathologic Response (pP) Following Preoperative Chemoradiation (CRT) , 2005, Annals of surgery.

[4]  H. Moch,et al.  Axillary Recurrence Rate in Breast Cancer Patients With Negative Sentinel Lymph Node (SLN) or SLN Micrometastases: Prospective Analysis of 150 Patients After SLN Biopsy , 2005, Annals of surgery.

[5]  G. Pruneri,et al.  Histopathologic examination of axillary sentinel lymph nodes in breast carcinoma patients , 2004, Journal of surgical oncology.

[6]  F. Shanahan,et al.  Prevalence of bone marrow micrometastases in esophagogastric cancer patients with and without neoadjuvant chemoradiotherapy. , 2004, The Journal of surgical research.

[7]  R. Weber,et al.  Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. , 2003, The New England journal of medicine.

[8]  P. Pairolero,et al.  Tumor response to induction chemoradiation: influence on survival after esophagectomy. , 2003, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  J. Ajani,et al.  Long-term outcome of phase II trial evaluating chemotherapy, chemoradiotherapy, and surgery for locoregionally advanced esophageal cancer. , 2003, International journal of radiation oncology, biology, physics.

[10]  V. Speights,et al.  Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. , 2003, Archives of pathology & laboratory medicine.

[11]  K. McMasters,et al.  The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. , 2001, American journal of surgery.

[12]  A. Luini,et al.  Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma , 2001, Cancer.

[13]  M. Iannettoni,et al.  Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  D. Weaver,et al.  Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma , 2000, Cancer.

[15]  F. Shanahan,et al.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments. , 1999, Gastroenterology.

[16]  E. Conant,et al.  Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast carcinoma , 1999, Cancer.

[17]  W. Richards,et al.  Pathologic prognostic factors in Barrett's‐associated adenocarcinoma , 1999, Cancer.

[18]  J. Ajani,et al.  Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. , 1998, The New England journal of medicine.

[19]  L. Karnell,et al.  National Cancer Data Base report on esophageal carcinoma , 1996, Cancer.

[20]  T. Walsh,et al.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. , 1996, The New England journal of medicine.

[21]  M. Cummings,et al.  Occult axillary node metastases in breast cancer: their detection and prognostic significance. , 1996, British Journal of Cancer.

[22]  H. Ide,et al.  Esophageal squamous cell carcinoma: Pathology and prognosis , 1994, World Journal of Surgery.

[23]  J. Tjandra,et al.  Detection and significance of occult metastases in node‐negative breast cancer , 1993, The British journal of surgery.

[24]  F. Clayton,et al.  Pathologic correlates of prognosis in lymph node‐positive breast carcinomas , 1993, Cancer.

[25]  J. Coindre,et al.  Prognostic significance of breast cancer axillary lymph node micrometastases assessed by two special techniques: reevaluation with longer follow-up. , 1992, British Journal of Cancer.

[26]  S. Steinberg,et al.  Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. , 1988, The Journal of thoracic and cardiovascular surgery.

[27]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[28]  S. Friedman,et al.  Importance of tumor cells in axillary node sinus margins ('clandestine' metastases) discovered by serial sectioning in operable breast carcinoma. , 1988, Acta oncologica.